Analyst Ratings for Talis Biomedical Corp. (TLIS)

TLIS Rating Summary

TLIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TLIS
Overall Rating: SELL   Rating Trend: Down   Avg. $ Target: $5.00 (+488.2%) * Over Last 12-Mos
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/18/2022 BTIG Mark A. Massaro Downgrade Sell
(Neutral)
1.00
(N/A)
1.42
(0.85)
-40.14% Details
1/7/2022 BofA Securities Derik de Bruin Downgrade Underperform
(Neutral)
3.00
(N/A)
3.53
(0.85)
-75.92% Details
Like TLIS Ratings? Also take a look at BHG, TALK, FSLR, OSH

TLIS Ratings News